Reni Benjamin

Stock Analyst at JMP Securities

(3.16)
# 1,198
Out of 4,442 analysts
117
Total ratings
44%
Success rate
1.07%
Average return

29 Stocks

BioAtla
May 23, 2024
Maintains: Market Outperform
Price Target: $12$5
Current: $1.71
Upside: +192.40%
Kura Oncology
May 16, 2024
Reiterates: Market Outperform
Price Target: $32
Current: $21.17
Upside: +51.16%
Werewolf Therapeutics
May 6, 2024
Reiterates: Market Outperform
Price Target: $12
Current: $4.88
Upside: +145.90%
Blueprint Medicines
May 3, 2024
Maintains: Market Outperform
Price Target: $114$125
Current: $102.81
Upside: +21.58%
Deciphera Pharmaceuticals
Apr 30, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $25.51
Upside: -
Sutro Biopharma
Apr 3, 2024
Reiterates: Market Outperform
Price Target: $17
Current: $4.14
Upside: +310.63%
Prelude Therapeutics
Mar 13, 2024
Initiates: Market Outperform
Price Target: $7
Current: $4.09
Upside: +71.15%
Sana Biotechnology
Mar 1, 2024
Maintains: Market Outperform
Price Target: $8$15
Current: $8.02
Upside: +87.03%
Iovance Biotherapeutics
Feb 20, 2024
Maintains: Market Outperform
Price Target: $18$25
Current: $10.01
Upside: +149.75%
Incyte
Feb 14, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $57.31
Upside: -
Inhibrx
Jan 23, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $34.14
Upside: -
Allogene Therapeutics
Jan 5, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $2.52
Upside: -
Bicycle Therapeutics
Dec 20, 2023
Maintains: Market Outperform
Price Target: $44$32
Current: $23.03
Upside: +38.95%
LAVA Therapeutics
Aug 23, 2023
Reiterates: Market Outperform
Price Target: $6
Current: $2.64
Upside: +127.27%
Adicet Bio
Jun 27, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $1.49
Upside: -
Cue Biopharma
May 15, 2023
Reiterates: Outperform
Price Target: $15
Current: $1.63
Upside: +823.08%
eFFECTOR Therapeutics
Jan 9, 2023
Maintains: Market Outperform
Price Target: $50$25
Current: $1.78
Upside: +1,304.49%
Compugen
Aug 8, 2022
Maintains: Market Outperform
Price Target: $8$4
Current: $2.44
Upside: +63.93%
MacroGenics
Feb 7, 2019
Upgrades: Market Perform
Price Target: n/a
Current: $4.55
Upside: -
REGENXBIO
Feb 5, 2019
Upgrades: Strong Buy
Price Target: n/a
Current: $14.92
Upside: -
Leap Therapeutics
Dec 19, 2018
Maintains: Outperform
Price Target: n/a
Current: $2.38
Upside: -
Voyager Therapeutics
Nov 15, 2018
Upgrades: Strong Buy
Price Target: n/a
Current: $8.23
Upside: -
Adverum Biotechnologies
Nov 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $7.60
Upside: -
Adaptimmune Therapeutics
Oct 22, 2018
Maintains: Outperform
Price Target: n/a
Current: $1.05
Upside: -
ADMA Biologics
Oct 12, 2018
Maintains: Outperform
Price Target: n/a
Current: $9.56
Upside: -
TG Therapeutics
Sep 25, 2018
Downgrades: Outperform
Price Target: n/a
Current: $16.71
Upside: -
UroGen Pharma
Nov 15, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $13.24
Upside: -
Organovo Holdings
Nov 10, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $1.00
Upside: -
Boundless Bio
Oct 12, 2017
Initiates: Market Perform
Price Target: n/a
Current: $11.31
Upside: -